SETD2 and clear cell renal carcinoma: In clear cell renal cell carcinoma (ccRCC), SETD2 mediates the trimethylation of α-tubulin at K40, which is required to maintain genomic stability, and loss of SETD2 function results in genomic instability and contributes to ccRCC tumorigenesis.